Pediatric and Off-Label Indications for Zostavax
Zostavax is a live, attenuated vaccine. This means that it contains a version of the virus that is weakened but still alive. Zostavax works by stimulating the immune system to respond to the virus in the vaccine, which helps the body to suppress the varicella-zoster virus, helping to prevent shingles.
Zostavax is approved only in people age 50 years and older. It should not be used in children and teens, and it should not be used to prevent chickenpox.
On occasion, your healthcare provider may recommend Zostavax for something other than the prevention of shingles. At this time, there are no universally accepted off-label Zostavax uses.